Trials / Unknown
UnknownNCT00356330
Safety of Cardiac Pacemakers in 3 Tesla MRI
Study to Evaluate Safety of Cardiac Pacemakers in MR Imaging at 3T Tesla
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 75 (planned)
- Sponsor
- University Hospital, Bonn · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
To evaluate short-term and long-term effects by MR imaging at 3T on the technical and functional status of cardiac pacemakers.
Detailed description
Recently, a shift could be observed from cardiac pacemakers being an absolute contraindication to being a relative contraindication for MR imaging at 1.5 Tesla, depending on a patient-per-patient risk-benefit-evaluation, which includes an urgent clinical need for MR imaging (other imaging modalities non-conclusive) and co-morbidities (especially cardiac co-morbidities). At the same time, MR imaging at 3 Tesla is evolving from a research application only to an important imaging modality today. Using the improved signal-to-noise-ratio, high field MR-Systems with a field strength of 3 Tesla offer a variety of diagnostic advantages to 1.5 Tesla systems. These advantages lead to a higher sensitivity and specificity in diagnosing, foremost neurological, disorders. In this study, we evaluate the safety of MR imaging of the brain in patients with cardiac pacemakers at 3T.
Conditions
Timeline
- First posted
- 2006-07-26
- Last updated
- 2007-04-11
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT00356330. Inclusion in this directory is not an endorsement.